5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators

被引：13

作者：

Kern, Jeffrey C. ^{[1
]}

Terefenko, Eugene ^{[1
]}

Trybulski, Eugene ^{[1
]}

Berrodin, Thomas J. ^{[2
]}

Cohen, Jeffrey ^{[2
]}

Winneker, Richard C. ^{[2
]}

Yudt, Matthew R. ^{[2
]}

Zhang, Zhiming ^{[2
]}

Zhu, Yuan ^{[2
]}

Zhang, Puwen ^{[1
]}

机构：

[1] Wyeth Ayerst Res, Chem Sci, Collegeville, PA 19426 USA

[2] Wyeth Ayerst Res, Musculoskeletal Biol, Collegeville, PA 19426 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 23期

关键词：

Progesterone receptor; Nuclear receptor; Progesterone receptor agonist; Progesterone receptor antagonist; 5-Aryl indanone; 5-Aryl indan-1-one oxime; 5-Aryl indan-1-ols; MIFEPRISTONE; ANTAGONISTS; POTENT; LIGANDS;

D O I：

10.1016/j.bmcl.2009.10.008

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel 5-aryl indanones, inden-1-one oximes, and inden-1-ols were synthesized and evaluated as progesterone receptor (PR) modulators using the T47D cell alkaline phosphatase assay. Both PR agonists and antagonists were achieved with appropriate 3- and 5-substitution from indanones and inden-1-ols while inden-1-one oximes provided only PR antagonists. Several compounds such as 10 and 11 demonstrated potent in vitro PR agonist potency similar to that of steroidal progesterone (1). In addition, a number of compounds (e. g., 12, 13, 17, 18) showed potent PR antagonist activity indicating the indanones and derivatives are promising PR modulator templates. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：6666 / 6669

页数：4

共 16 条

[1] MIFEPRISTONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL
BROGDEN, RN
GOA, KL
FAULDS, D
[J]. DRUGS, 1993, 45 (03) : 384 - 409
[2] Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double-blind randomized control trial of 2 and 5 mg per day for 120 days
Brown, A
Cheng, LN
Lin, SQ
Baird, DT
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) : 63 - 70
[3] Novel pyrrole-containing progesterone receptor modulators
Collins, MA
Hudak, V
Bender, R
Fensome, A
Zhang, PW
Miller, L
Winneker, RC
Zhang, ZM
Zhu, Y
Cohen, J
Unwalla, RJ
Wrobel, J
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2185 - 2189
[4] NONSTEROIDAL PROGESTERONE-RECEPTOR LIGANDS .2. HIGH-AFFINITY LIGANDS WITH SELECTIVITY FOR BONE CELL PROGESTERONE RECEPTORS
COMBS, DW
REESE, K
CORNELIUS, LAM
GUNNET, JW
CRYAN, EV
GRANGER, KS
JORDAN, JJ
DEMAREST, KT
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) : 4880 - 4884
[5] Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
Fensome, A
Bender, R
Chopra, A
Cohen, J
Collins, MA
Hudak, V
Malakian, K
Lockhead, S
Olland, A
Svenson, K
Terefenko, EA
Unwalla, RJ
Wilhelm, JM
Wolfrom, S
Zhu, Y
Zhang, ZM
Zhang, PW
Winneker, RC
Wrobel, J
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5092 - 5095
[6] Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists
Jain, Nareshkumar
Allan, George
Linton, Olivia
Tannenbaum, Pamela
Chen, Xin
Xu, Jun
Zhu, Peifang
Gunnet, Joseph
Demarest, Keith
Lundeen, Scott
Murray, William
Sui, Zhihua
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (14) : 3977 - 3980
[7] 1,5-dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5′-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators
Kern, Jeffrey C.
Terefenko, Eugene A.
Fensome, Andrew
Unwalla, Ray
Wrobel, Jay
Cohen, Jeffrey
Zhu, Yuan
Berrodin, Thomas J.
Yudt, Matthew R.
Winneker, Richard C.
Zhang, Zhiming
Zhang, Puwen
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5015 - 5017
[8] Kettel LM, 1996, FERTIL STERIL, V65, P23
[9] Synthesis and structure-activity relationships of new non-steroidal progesterone receptor ligands
Kurihara, K
Tanabe, K
Yamamoto, Y
Shinei, R
Ajito, K
Okonogi, T
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1837 - 1842
[10] REGRESSION OF UTERINE LEIOMYOMATA IN RESPONSE TO THE ANTIPROGESTERONE RU-486
MURPHY, AA
KETTEL, LM
MORALES, AJ
ROBERTS, VJ
YEN, SSC
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) : 513 - 517

← 1 2 →